CoChat

Bimodal Effect on Pancreatic β-Cells of Secretory Products From Normal or Insulin-Resistant Human Skeletal Muscle

Open access

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Type 2 diabetes is characterized by insulin resistance with a relative deficiency in insulin secretion. This study explored the potential communication between insulin-resistant human skeletal muscle and primary (human and rat) β-cells. RESEARCH DESIGN AND METHODS: Human skeletal muscle cells were cultured for up to 24 h with tumor necrosis factor (TNF)-α to induce insulin resistance, and mRNA expression for cytokines was analyzed and compared with controls (without TNF-α). Conditioned media were collected and candidate cytokines were measured by antibody array. Human and rat primary β-cells were used to explore the impact of exposure to conditioned media for 24 h on apoptosis, proliferation, short-term insulin secretion, and key signaling protein phosphorylation and expression. RESULTS: Human myotubes express and release a different panel of myokines depending on their insulin sensitivity, with each panel exerting differential effects on β-cells. Conditioned medium from control myotubes increased proliferation and glucose-stimulated insulin secretion (GSIS) from primary β-cells, whereas conditioned medium from TNF-α–treated insulin-resistant myotubes (TMs) exerted detrimental effects that were either independent (increased apoptosis and decreased proliferation) or dependent on the presence of TNF-α in TM (blunted GSIS). Knockdown of β-cell mitogen-activated protein 4 kinase 4 prevented these effects. Glucagon-like peptide 1 protected β-cells against decreased proliferation and apoptosis evoked by TMs, while interleukin-1 receptor antagonist only prevented the latter. CONCLUSIONS: Taken together, these data suggest a possible new route of communication between skeletal muscle and β-cells that is modulated by insulin resistance and could contribute to normal β-cell functional mass in healthy subjects, as well as the decrease seen in type 2 diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db10-1178

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG. 1. Effect of TNF-α on insulin sensitivity and apoptosis in human skeletal muscle cells. A: Human myotubes were cultured 24 h ± 20 ng/mL TNF-α, and IRS-1 protein expression was measured by Western blot (normalized to actin). Mean ± SE, 5 independent experiments. B: 24 h after incubation with TNF-α, human skeletal muscle cells were treated with 100 nmol/L insulin either for 5 min to induce IRS-1 tyrosine phosphorylation or 10 min to measure Akt phosphorylation. Representative immunoblots are shown for IRS-1 tyrosine (Tyr) phosphorylation (upper panel) and Akt Ser479 phosphorylation (lower panel). C: Effect of different times of TNF-α treatment (20 ng/mL) on human skeletal muscle cell death measured by TUNEL assay. n = 5 independent experiments. D: Effect of different TNF-α concentrations (24 h) on human primary skeletal muscle cell death measured by TUNEL assay. n = 5 independent experiments; *P < 0.05 vs. control. IP, immunoprecipitation; IB, immunoblotting.
FIG. 1. Effect of TNF-α on insulin sensitivity and apoptosis in human skeletal muscle cells. A: Human myotubes were cultured 24 h ± 20 ng/mL TNF-α, and IRS-1 protein expression was measured by Western blot (normalized to actin). Mean ± SE, 5 independent experiments. B: 24 h after incubation with TNF-α, human skeletal muscle cells were treated with 100 nmol/L insulin either for 5 min to induce IRS-1 tyrosine phosphorylation or 10 min to measure Akt phosphorylation. Representative immunoblots are shown for IRS-1 tyrosine (Tyr) phosphorylation (upper panel) and Akt Ser479 phosphorylation (lower panel). C: Effect of different times of TNF-α treatment (20 ng/mL) on human skeletal muscle cell death measured by TUNEL assay. n = 5 independent experiments. D: Effect of different TNF-α concentrations (24 h) on human primary skeletal muscle cell death measured by TUNEL assay. n = 5 independent experiments; *P < 0.05 vs. control. IP, immunoprecipitation; IB, immunoblotting.CC BY-NC-ND · PubMed Central
FIG. 2. Effect of TNF-α on expression of cytokine genes in human skeletal muscle cells. A: Human myotubes were cultured 8 h ± 20 ng/mL TNF-α, and cytokine mRNA levels were monitored by hybridization to Oligo nucleotide array membranes. White circles show modified mRNA levels between the two conditions on representative membranes out of four different experiments. B: Cytokine mRNA levels were measured by quantitative RT-PCR (qRT-PCR). The data are the mean value of four independent experiments, and mRNA expression levels were normalized to cyclophilin A. HM + TNF, human skeletal muscle cells after 8-h culture with TNF-α; HM, human skeletal muscle cells after 8-h culture without TNF-α.
FIG. 2. Effect of TNF-α on expression of cytokine genes in human skeletal muscle cells. A: Human myotubes were cultured 8 h ± 20 ng/mL TNF-α, and cytokine mRNA levels were monitored by hybridization to Oligo nucleotide array membranes. White circles show modified mRNA levels between the two conditions on representative membranes out of four different experiments. B: Cytokine mRNA levels were measured by quantitative RT-PCR (qRT-PCR). The data are the mean value of four independent experiments, and mRNA expression levels were normalized to cyclophilin A. HM + TNF, human skeletal muscle cells after 8-h culture with TNF-α; HM, human skeletal muscle cells after 8-h culture without TNF-α.CC BY-NC-ND · PubMed Central
FIG. 3. Effect of TNF-α on human skeletal muscle cell cytokine secretion. A: Human myotubes were cultured 24 h ± 20 ng/mL TNF-α, and cytokine levels in the conditioned media were monitored by hybridization to human chemokine + cytokine array membranes. White circles show modified protein levels between the two conditions on representative membranes from three different experiments. B: Each membrane was quantified using Multi Gauge software, and the intensity was normalized to internal positive controls for comparison. n = 3 independent experiments. TM, medium from human skeletal muscle cells cultured 24 h with TNF-α; CM, medium from human skeletal muscle cells cultured 24 h without TNF-α.
FIG. 3. Effect of TNF-α on human skeletal muscle cell cytokine secretion. A: Human myotubes were cultured 24 h ± 20 ng/mL TNF-α, and cytokine levels in the conditioned media were monitored by hybridization to human chemokine + cytokine array membranes. White circles show modified protein levels between the two conditions on representative membranes from three different experiments. B: Each membrane was quantified using Multi Gauge software, and the intensity was normalized to internal positive controls for comparison. n = 3 independent experiments. TM, medium from human skeletal muscle cells cultured 24 h with TNF-α; CM, medium from human skeletal muscle cells cultured 24 h without TNF-α.CC BY-NC-ND · PubMed Central
FIG. 4. Effect of conditioned medium on primary β-cell proliferation, survival, and GSIS. Conditioned medium was obtained by culturing human myotubes for 24 h with (TM) or without (CM) 20 ng/mL TNF-α. Additional control conditions were as follows: CTRL, culture medium not previously exposed to skeletal muscle cells; CM + TNF, 20 ng/mL TNF-α added to CM immediately before exposure to β-cells. A: Proliferation of rat primary β-cells measured by BrdU incorporation. Cells were grown under standard culture conditions (20% FCS, 11.2 mmol/L glucose) and treated for 48 h with the different conditioned media; BrdU was added for the last 24 h. β-Cells were identified by insulin immunofluorescence. n = 7 independent experiments. B and C: Rat and human primary β-cell apoptosis. Cell death was measured by TUNEL. n = 7 (rats) and n = 5 (human) independent experiments. *P < 0.05. D and E: Glucose-stimulated insulin secretion from rat and human primary β-cells measured during 60 min at 2.8 mmol/L glucose (white bars = basal secretion) following by 60 min at 16.7 mmol/L glucose (dark bars = stimulated secretion). Secretion is expressed as a percentage total insulin content. n = 7 (rats) and n = 5 (human) independent experiments. *P < 0.05.
FIG. 4. Effect of conditioned medium on primary β-cell proliferation, survival, and GSIS. Conditioned medium was obtained by culturing human myotubes for 24 h with (TM) or without (CM) 20 ng/mL TNF-α. Additional control conditions were as follows: CTRL, culture medium not previously exposed to skeletal muscle cells; CM + TNF, 20 ng/mL TNF-α added to CM immediately before exposure to β-cells. A: Proliferation of rat primary β-cells measured by BrdU incorporation. Cells were grown under standard culture conditions (20% FCS, 11.2 mmol/L glucose) and treated for 48 h with the different conditioned media; BrdU was added for the last 24 h. β-Cells were identified by insulin immunofluorescence. n = 7 independent experiments. B and C: Rat and human primary β-cell apoptosis. Cell death was measured by TUNEL. n = 7 (rats) and n = 5 (human) independent experiments. *P < 0.05. D and E: Glucose-stimulated insulin secretion from rat and human primary β-cells measured during 60 min at 2.8 mmol/L glucose (white bars = basal secretion) following by 60 min at 16.7 mmol/L glucose (dark bars = stimulated secretion). Secretion is expressed as a percentage total insulin content. n = 7 (rats) and n = 5 (human) independent experiments. *P < 0.05.CC BY-NC-ND · PubMed Central
FIG. 5. Action of conditioned medium on Akt, ERK, AS160, and Akt substrates phosphorylation after glucose stimulation, or IRS-1 and -2 protein expression in rat primary β-cells. Conditioned media and abbreviations as described in the legend to Fig. 3. After 24-h culture in conditioned medium, β-cells were incubated 1 h at 2.8 mmol/L or 16.7 mmol/L glucose (Glc). Open bars = 2.8 mmol/L glucose; closed bars = 16.7 mmol/L glucose. Western blots were scanned and data normalized to total protein or actin as indicated. N = 3 independent experiments. A: Akt Ser 473 phosphorylation. *P < 0.05; **P < 0.01. B: ERK1/2 phosphorylation. **P < 0.01. C: AS160 phosphorylation. *P < 0.05; **P < 0.01. D: Ser/Thr phosphorylation of Akt substrates (white crosses = CM effect; black crosses = TM effect). E and F: IRS-1 (E) and IRS-2 (F) protein expression. *P < 0.05. CTRL, control.
FIG. 5. Action of conditioned medium on Akt, ERK, AS160, and Akt substrates phosphorylation after glucose stimulation, or IRS-1 and -2 protein expression in rat primary β-cells. Conditioned media and abbreviations as described in the legend to Fig. 3. After 24-h culture in conditioned medium, β-cells were incubated 1 h at 2.8 mmol/L or 16.7 mmol/L glucose (Glc). Open bars = 2.8 mmol/L glucose; closed bars = 16.7 mmol/L glucose. Western blots were scanned and data normalized to total protein or actin as indicated. N = 3 independent experiments. A: Akt Ser 473 phosphorylation. *P < 0.05; **P < 0.01. B: ERK1/2 phosphorylation. **P < 0.01. C: AS160 phosphorylation. *P < 0.05; **P < 0.01. D: Ser/Thr phosphorylation of Akt substrates (white crosses = CM effect; black crosses = TM effect). E and F: IRS-1 (E) and IRS-2 (F) protein expression. *P < 0.05. CTRL, control.CC BY-NC-ND · PubMed Central
FIG. 6. Action of conditioned medium on IRS-1, IRS-2, and MAP4K4 mRNA expression and effect of MAP4K4 knockdown. Conditioned media and abbreviations as described in the legend to Fig. 3. Rat primary β-cells were used for n = 5 independent experiments. A–C: IRS-1, IRS-2, and MAP4K4 mRNA expression were measured by quantitative real-time RT-PCR in β-cells. *P < 0.05. D–F: Proliferation (BrdU incorporation) (D) and apoptosis (TUNEL) (E) were measured in β-cells transfected with scrambled (Scr) (open bars = Scr) or with MAP4K4 small interfering RNA (siRNA) Si MAP4K4 (closed bars = Si MAP4K4). F: Insulin secretion was measured using β-cells transfected with scrambled (Scr) or with Si MAP4K4 and incubated for 60 min at 2.8 mmol/L glucose (open bars) followed by 60 min at 16.7 mmol/L glucose (closed bars). *P < 0.05. CTRL, control.
FIG. 6. Action of conditioned medium on IRS-1, IRS-2, and MAP4K4 mRNA expression and effect of MAP4K4 knockdown. Conditioned media and abbreviations as described in the legend to Fig. 3. Rat primary β-cells were used for n = 5 independent experiments. A–C: IRS-1, IRS-2, and MAP4K4 mRNA expression were measured by quantitative real-time RT-PCR in β-cells. *P < 0.05. D–F: Proliferation (BrdU incorporation) (D) and apoptosis (TUNEL) (E) were measured in β-cells transfected with scrambled (Scr) (open bars = Scr) or with MAP4K4 small interfering RNA (siRNA) Si MAP4K4 (closed bars = Si MAP4K4). F: Insulin secretion was measured using β-cells transfected with scrambled (Scr) or with Si MAP4K4 and incubated for 60 min at 2.8 mmol/L glucose (open bars) followed by 60 min at 16.7 mmol/L glucose (closed bars). *P < 0.05. CTRL, control.CC BY-NC-ND · PubMed Central
FIG. 7. Effect of IL-1RA, GLP-1, or anti–TNF-α on rat primary β-cells exposed to conditioned medium. Conditioned media and abbreviations as described in the legend to Fig. 3. Rat primary β-cells were treated 48 h with IL-1RA (1 μg/mL) and conditioned medium. A: BrdU was added during the last 24 h to measure proliferation. B: Conditioned medium added for the last 24 h and cell death was measured by TUNEL. C: Rat primary β-cells were treated 48 h with conditioned medium, with or without GLP-1 (100 nmol/L), and BrdU was added the last 24 h to measure proliferation. D: Rat primary β-cells were treated 48 h with or without GLP-1, and conditioned medium was added for the last 24 h. Cell death was measured as described. n = 3 independent experiments. *P < 0.05; **P < 0.01. E: Insulin secretion was measured using rat primary β-cells treated for 24 h with the different conditioned media with or without TNF-α blockade (2 ng/mL Ethanercept) and then incubated for 60 min at 2.8 mmol/L glucose (open bars) followed by 60 min at 16.7 mmol/L glucose (closed bars); *P < 0.05. F and G: Rat primary β-cells treated with the different conditioned media with or without Ethanercept and were used to assess cell death using TUNEL assay (F) and cell proliferation (G) as described. n = 4 independent experiments; *P < 0.05 for TNF-α blockade. CTRL, control.
FIG. 7. Effect of IL-1RA, GLP-1, or anti–TNF-α on rat primary β-cells exposed to conditioned medium. Conditioned media and abbreviations as described in the legend to Fig. 3. Rat primary β-cells were treated 48 h with IL-1RA (1 μg/mL) and conditioned medium. A: BrdU was added during the last 24 h to measure proliferation. B: Conditioned medium added for the last 24 h and cell death was measured by TUNEL. C: Rat primary β-cells were treated 48 h with conditioned medium, with or without GLP-1 (100 nmol/L), and BrdU was added the last 24 h to measure proliferation. D: Rat primary β-cells were treated 48 h with or without GLP-1, and conditioned medium was added for the last 24 h. Cell death was measured as described. n = 3 independent experiments. *P < 0.05; **P < 0.01. E: Insulin secretion was measured using rat primary β-cells treated for 24 h with the different conditioned media with or without TNF-α blockade (2 ng/mL Ethanercept) and then incubated for 60 min at 2.8 mmol/L glucose (open bars) followed by 60 min at 16.7 mmol/L glucose (closed bars); *P < 0.05. F and G: Rat primary β-cells treated with the different conditioned media with or without Ethanercept and were used to assess cell death using TUNEL assay (F) and cell proliferation (G) as described. n = 4 independent experiments; *P < 0.05 for TNF-α blockade. CTRL, control.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Cited by

See all 122

Metadata

Authors
Bouzakri, K., Plomgaard, P., Berney, T., Donath, M. Y., Pedersen, B. K., & Halban, P. A.
Affiliations
  • University of Geneva (CH)
  • University of Copenhagen (DK)
  • University Hospital of Geneva (CH)
  • University Hospital of Basel (CH)
  • Department of Infectious Diseases and the Copenhagen Muscle Research Centre, The Centre of Inflammation and Metabolism, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
Corresponding author
Bouzakri, Karim
Venue
Diabetes
Published
2011-03-22
Volume
60
Issue
4
Pages
1111-1121
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2170623101
Cited by
122
References
47
Citations by year
2026: 2 · 2025: 6 · 2024: 4 · 2023: 7 · 2022: 9 · 2021: 9 · 2020: 9 · 2019: 8 · 2018: 8 · 2017: 12 · 2016: 10 · 2015: 9 · 2014: 12 · 2013: 10 · 2012: 5
FWCI
9.48
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Archive ouverte UNIGE (University of Geneva) (publishedVersion)
  • HAL (submittedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
  • Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
Funders
  • Strategiske Forskningsråd (09-067009 and 09-075724, 09–067009, 09 – 075724)
  • Sundhed og Sygdom, Det Frie Forskningsråd
  • National Research Foundation
  • Danmarks Grundforskningsfond (# 02-512-55, 09-067009, 09-075724)
  • Ministério da Ciência, Tecnologia e Inovação
  • Region Hovedstaden
  • Université de Genève
  • Diabetesforeningen
  • Medical Research Council
  • Center for Strategic Research
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Keywords
pancreatic beta cells, skeletal muscle, insulin resistance, type 2 diabetes, myokines, TNF-α, glucose-stimulated insulin secretion, beta-cell apoptosis, beta-cell proliferation, MAPK4, glucagon-like peptide-1, interleukin-1 receptor antagonist, cytokines
MeSH terms
Insulin Secretion, Animals, Cells, Cultured, Humans, Insulin, Insulin Resistance, Male, Tumor Necrosis Factor-alpha, Cytokines, Culture Media, Conditioned, Rats, Wistar, Apoptosis, Protein Serine-Threonine Kinases, Muscle Fibers, Skeletal, In Situ Nick-End Labeling, RNA Interference, Cell Proliferation, Insulin-Secreting Cells, Rats, Insulin Receptor Substrate Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.